The transplant diagnostics market size was exhibited at USD 6.55 billion in 2024 and is projected to hit around USD 13.37 billion by 2034, growing at a CAGR of 7.4% during the forecast period 2024 to 2034.
The demand for transplant diagnostics is expected to grow owing to factors such as increasing geriatric population, prevalence of chronic disease and advancements in transplantation procedures.
As chronic diseases like heart failure, kidney diseases, and liver disorders are on the rise, the need for organ transplantation as a life-saving treatment is also increasing. This increase in transplantation process highlights the importance of accurate and advanced diagnostic tools to ensure that donors and recipients are compatible, reducing the risk of organ failure and improving the success rates of transplantation.
Consequently, the market is driven by the rising incidence of organ, leading to the continuous development of innovative transplant diagnostic technologies and improved medical devices to meet the growing hospitals & specialized clinical demand and ultimately enhance patient outcomes.
| Report Coverage | Details |
| Market Size in 2025 | USD 7.03 Billion |
| Market Size by 2034 | USD 13.37 Billion |
| Growth Rate From 2024 to 2034 | CAGR of 7.4% |
| Base Year | 2024 |
| Forecast Period | 2024-2034 |
| Segments Covered | Test, Product, Application, Transplant Area, End use Region |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regional Covered | North America; Europe; Asia Pacific; Latin America; MEA |
| Key Companies Profiled | Thermo Fisher Scientific, Inc.; Illumina, Inc.; F. Hoffmann La-Roche Ltd; Abbott; QIAGEN; Bruker; BD (Becton, Dickinson and Company); Werfen (Immucor, Inc.); Bio-Rad Laboratories, Inc.; Omixon Inc. |
In 2024, the molecular assays segment dominated the market and accounted for largest revenue share of 41.5%. Molecular assays offer more features compared to non-molecular assays, it is a more sensitive method allowing detection of lower amounts of infectious agents and it tends to be accurate. Furthermore, molecular assays are widely used in pre-surgical diagnostics procedures for testing the compatibility of donor and a recipient.
The sequencing-based molecular assays are expected to witness the fastest CAGR of 8.3% during the forecast period. The current research and development in transplant diagnostics prioritize more accurate and highly sensitive tests. This focus on improved diagnostics has the potential to enhance the patient outcomes and drive the future demand for sequencing based molecular assays.
In 2024, the reagents and consumables segment dominated the market and accounted for largest revenue share in 2024, owing to the growing demand for effective and early profiling during organ transportation.
The software and services segment is expected to witness the fastest CAGR during the forecast period, owing to the latest developments in the software industry and improved services offered by the market players. Moreover, the recent development in software technology and with the induction of Artificial Intelligence (AI) and Machine Learning (ML) are giving more efficient output.
Diagnostics dominated the market and accounted for the largest market revenue share of 71.1% in 2024. Research application on the other hand, is expected to witness a significant growth during the forecast period.
Diagnostics enables matching recipient and organ donor by evaluating compatibility primarily via Human Leukocyte Antigen (HLA) testing. Transplant diagnostics includes screening of both recipients & donors for viral infections ensuring that infections are detected before transplantation to prevent their transmission.
The solid organ transplantation segment dominated the market in 2024 and accounted for a revenue share of 45.5% in 2024, owing to the rising cardiovascular, liver and lung diseases across the globe.
Stem cell transplantation is expected to witness the fastest CAGR during the forecast period. Stem cells are used in several treatments like treatment of cardiovascular and autoimmune diseases.
Hospitals and transplant centers dominated the market with a revenue of 2.72 billion in 2024, owing to the rising healthcare expenditure and use of advanced medical devices in these settings. Hospitals are the integral components of the organ transplantation process. In addition, several countries are focusing more on the development of hospitals and specialized centers that focus on organ transplantation.
Research and academic institutes are expected to witness the fastest CAGR during the forecast period. Government and private institutes are focusing more on efficient solutions for organ transplantation and diagnostics. Moreover, the HRSA, an agency of the U.S. Government, in March 2024, announced organ procurement and transplantation network modernization initiative to strengthen accountability and transparency in organ procurement and transplantation network (OPTN).
In 2024, the North America transplant diagnostics market held a considerable market share of 33.0%, owing to the availability of well-developed health infrastructure and a high adoption of advanced medical technologies. Furthermore, a rise in investment in research and development for organ transplantation is driving the market. According to Health Resource & Service Administration (HRSA), as of March 2024, more than 46,000 organ transplants were performed in U.S.
U.S Transplant Diagnostics Market Trends
In 2024, the transplant diagnostics market in the U.S. captured a significant market share, owing to advanced healthcare infrastructure, advanced medical technology & devices and rising awareness among citizens about organ transplantation.
Europe Transplant Diagnostics Market Trends
The Europe transplant diagnostics market held a significant market share in 2024. This growth is attributed to a rise in healthcare budget and availability of professional surgeons and well-equipped advanced healthcare technologies in the region.
The UK transplant diagnostics market held the largest market share in Europe, owing to availability of skilled surgeons, growing healthcare expenditure, and highly developed healthcare infrastructure.
Germany transplant diagnostics market is expected to grow at the fastest CAGR during the forecast period owing to the increasing healthcare expenditure and adoption of advanced medical devices.
Asia Pacific Transplant Diagnostics Market Trends
The transplant diagnostics market in Asia Pacific is projected to witness the fastest CAGR of 10.12% during the forecast period. The growth is driven by advancements in healthcare infrastructure, increasing healthcare expenditure and rising disposable income. Also, there has been significant increase in prevalence of chronic disease in middle age and geriatric population especially in countries such as China, Japan and India.
The China transplant diagnostics market held the largest market share in 2024 owing to the improved healthcare professionals and infrastructure and awareness among public about importance of organ transplant.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the transplant diagnostics market
By Test
By Product
By Application
By Transplant Area
By End Use
By Regional
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers